Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Journey Medical (DERM) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$786000.0.

  • Journey Medical's Non Operating Income fell 25595.24% to -$786000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 146256.41%. This contributed to the annual value of -$934000.0 for FY2024, which is 4008.98% up from last year.
  • As of Q3 2025, Journey Medical's Non Operating Income stood at -$786000.0, which was down 25595.24% from -$860000.0 recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's Non Operating Income peaked at $504000.0 during Q3 2024, and registered a low of -$4.4 million during Q4 2021.
  • For the 5-year period, Journey Medical's Non Operating Income averaged around -$758684.2, with its median value being -$578000.0 (2022).
  • As far as peak fluctuations go, Journey Medical's Non Operating Income crashed by 201601.94% in 2021, and later skyrocketed by 23961.22% in 2024.
  • Over the past 5 years, Journey Medical's Non Operating Income (Quarter) stood at -$4.4 million in 2021, then soared by 85.46% to -$634000.0 in 2022, then skyrocketed by 113.72% to $87000.0 in 2023, then tumbled by 849.43% to -$652000.0 in 2024, then dropped by 20.55% to -$786000.0 in 2025.
  • Its Non Operating Income was -$786000.0 in Q3 2025, compared to -$860000.0 in Q2 2025 and -$749000.0 in Q1 2025.